Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (231-240 of 359) with videos related to

Pageof 36
Sort By:
Nuclear Medicine and Biology|October 26, 2005
Measurement of input functions in rodents: challenges and solutionsRichard Laforest, Terry L Sharp, John A Engelbach, et al.
Scientific Reports|October 28, 2020
pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgeryTroy Crawford, Anna Moshnikova, Sean Roles, et al.
Nature Chemistry|June 21, 2014
Development of a minimal saponin vaccine adjuvant based on QS-21Alberto Fernández-Tejada, Eric K Chea, Constantine George, et al.
Nuclear Medicine and Biology|February 5, 2005
Basic characterization of 64Cu-ATSM as a radiotherapy agentAtsushi Obata, Shingo Kasamatsu, Jason S Lewis, et al.
Diseases of the Colon and Rectum|August 7, 2008
Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot studyDavid W Dietz, Farrokh Dehdashti, Perry W Grigsby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein NanoparticlesCarlos Pérez-Medina, Jun Tang, Dalya Abdel-Atti, et al.
Molecular Cancer Therapeutics|August 5, 2021
ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal AdenocarcinomaKelly E Henry, Kyeara N Mack, Veronica L Nagle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2021
Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAMSai Kiran Sharma, Maya Suzuki, Hong Xu, et al.
Nuclear Medicine and Biology|November 30, 2024
Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancerKyeara N Mack, David Bauer, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2013
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PETYelena Y Janjigian, Nerissa Viola-Villegas, Jason P Holland, et al.
Pageof 36

Showing results (231-240 of 359) with videos related to

Sort By:
Pageof 36
Nuclear Medicine and Biology|October 26, 2005
Measurement of input functions in rodents: challenges and solutionsRichard Laforest, Terry L Sharp, John A Engelbach, et al.
Scientific Reports|October 28, 2020
pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgeryTroy Crawford, Anna Moshnikova, Sean Roles, et al.
Nature Chemistry|June 21, 2014
Development of a minimal saponin vaccine adjuvant based on QS-21Alberto Fernández-Tejada, Eric K Chea, Constantine George, et al.
Nuclear Medicine and Biology|February 5, 2005
Basic characterization of 64Cu-ATSM as a radiotherapy agentAtsushi Obata, Shingo Kasamatsu, Jason S Lewis, et al.
Diseases of the Colon and Rectum|August 7, 2008
Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot studyDavid W Dietz, Farrokh Dehdashti, Perry W Grigsby, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 27, 2015
PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein NanoparticlesCarlos Pérez-Medina, Jun Tang, Dalya Abdel-Atti, et al.
Molecular Cancer Therapeutics|August 5, 2021
ERK Inhibition Improves Anti-PD-L1 Immune Checkpoint Blockade in Preclinical Pancreatic Ductal AdenocarcinomaKelly E Henry, Kyeara N Mack, Veronica L Nagle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2021
Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAMSai Kiran Sharma, Maya Suzuki, Hong Xu, et al.
Nuclear Medicine and Biology|November 30, 2024
Pretargeted alpha therapy in MUC16-positive high-grade serous ovarian cancerKyeara N Mack, David Bauer, Lukas M Carter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 13, 2013
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PETYelena Y Janjigian, Nerissa Viola-Villegas, Jason P Holland, et al.
Pageof 36